#metformin

#metformin

A common diabetes medication does not help people with peripheral artery disease (PAD) and without diabetes walk farther, according to results from a major U.S. clinical trial published in JAMA. Peripheral artery disease (PAD) is a serious condition that affects blood flow to the legs, making walking painful and difficult. It impacts approximately 12 million adults in the U.S. and is linked to higher risks of heart attack and stroke.

The study found that, in people with prediabetes, metformin lowered the risk of diabetes by roughly a third; the life-style intervention cut the risk by more than half.